By improving our Patient-derived iPSC model using biological replicates, isogenic Controls, and naïve iPSCs, it might be possible to separate the consequences of LMNA haploinsufficiency from confounding factors and to continue testing the ‘gene expression’ hypothesis for LMNA-related DCM. The gene discussed is LMNA; the disease is familial dilated cardiomyopathy.